Domain Associates and Apax Partners each invested $9 million into the specialty pharmaceutical company. New Enterprise Associates invested $8 million, and ESP Pharma’s management also invested $2 million.

Partner Michael Sanders led the deal from Crosby’s Century City office. He said the deal went through rather quickly, starting with the negotiating of a term sheet in mid-March and closure of the deal by the end of May.